Biden Admin Seeks Broader Review of Marketing Materials, But Will Trump Admin See Overreach?

  • Dec 05, 2024

    While the Joe Biden administration has applied many regulatory tweaks to the Medicare Advantage program in the name of improving the consumer experience, industry observers expect the incoming Donald Trump administration will take a more plan-friendly approach from multiple angles. One of those is with respect to sales and marketing, suggests longtime marketing executive John Selby, and there is “an expectation that the new administration will go easier on brokers who are really feeling pressured and stressed” by changes in a delayed proposal around compensation.

    Meanwhile, a proposed rule issued on Nov. 26 contains multiple marketing-related changes for plan year 2026 that could be revisited by the Trump administration, sources tell AIS Health, a division of MMIT. The most significant of those proposals is “opening the lens back up” to a time when more marketing materials were subject to review, observes Steve Arbaugh, president and CEO of ATTAC Consulting Group.

    Read more
    © 2024 MMIT
  • Lauren Flynn Kelly

    Lauren has been covering health business issues since the early 2000s and specializes in in-depth reporting on Medicare Advantage, managed Medicaid and Medicare Part D. She also possesses a deep understanding of the complex world of pharmacy benefit management, having written AIS Health’s Radar on Drug Benefits from 2004 to 2005 and again from 2011 to 2016. In addition to her role as managing editor of Radar on Medicare Advantage, she oversees AIS Health’s publications and manages the health editorial staff. She graduated from Vassar College with a B.A. in English.

The Latest
Meet Our Reporters

Meet Our Reporters

×